Point72 Asset Management’s OncoSec Medical Incorporated ONCS Stock Holding History

Point72 Asset Management’s Portfolio ONCS Stock Details ONCS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-2,094	Closed	-$295K	–	1339
2018 Q4	$295K	Sell	2,094 -6,206	-75%	-$1.56M	﹤0.01%	893
2018 Q3	$2.56M	Sell	8,300 -1,768	-18%	-$543K	0.01%	725
2018 Q2	$3.06M	Sell	10,068 -4,546	-31%	-$1.59M	0.01%	704
2018 Q1	$6.04M	Buy	14,614 +4,705	+47%	+$1.93M	0.03%	533
2017 Q4	$3.54M	Buy	+9,909	New	+$3.47M	0.02%	648

Other funds holding ONCS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

IECM

Intrinsic Edge Capital Management Chicago, Illinois $603M AUM 66.97% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

DADC

D.A. Davidson & Co Great Falls, Montana $16.5B AUM 19.94% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

MSAM

Moloney Securities Asset Management Manchester, Missouri $840M AUM 18.11% 1-Year Est. Return

Point72 Asset Management's ONCS Position: Q1 2019 in Review

Point72 Asset Management sold out of OncoSec Medical Incorporated (ONCS) in Q1 2019, closing a stake of 2,094 shares — an estimated $295K sold.

Point72 Asset Management first reported a position in ONCS in Q4 2017 and held it in 5 quarters. The position peaked at $6.04M in Q1 2018. 30 funds tracked by Wall St. Rank hold ONCS as of Q1 2019.

Point72 Asset Management reported no remaining OncoSec Medical Incorporated position as of Q1 2019 after selling out during the quarter.
Point72 Asset Management sold 2,094 OncoSec Medical Incorporated shares in Q1 2019, an estimated $295K.
Point72 Asset Management first reported a position in OncoSec Medical Incorporated in Q4 2017 and held it in 5 quarters.
Point72 Asset Management's OncoSec Medical Incorporated position peaked at $6.04M in Q1 2018.
30 funds tracked by Wall St. Rank held OncoSec Medical Incorporated as of Q1 2019.

Based on Point72 Asset Management's 13F filing for Q1 2019, filed 15 May 2019.